Quality of life analyses from vinorelbine (Navelbine) clinical trials of women with metastatic breast cancer.

@article{Bertsch1995QualityOL,
  title={Quality of life analyses from vinorelbine (Navelbine) clinical trials of women with metastatic breast cancer.},
  author={Linda Bertsch and Gary W. Donaldson},
  journal={Seminars in oncology},
  year={1995},
  volume={22 2 Suppl 5},
  pages={45-53; discussion 53-4}
}
The effect of therapy on a patient's quality of life (QOL) is an important factor in choosing a treatment, especially when the primary intent of therapy is palliation of symptoms. An increasing recognition of the importance of QOL prompted inclusion of QOL assessments in a number of clinical trials of women with breast cancer. This report describes two clinical trials in which women with metastatic breast cancer were treated with intravenous (IV) vinorelbine (Navelbine; Burroughs Wellcome Co… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

Similar Papers

Loading similar papers…